Cancer Conversations™: Experts Discuss the New Immunotherapy Paradigm in Endometrial Cancer

Download this slideset from a panel of international experts on current evidence for immunotherapy for patients with endometrial cancer.

This slideset is intended for clinicians practicing medicine outside of the United States.

person default
Mansoor Raza Mirza, MD
Bradley J. Monk, MD, FACS, FACOG
Prof Isabelle Ray-Coquard, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 719 KB
Released: March 2, 2021

Acknowledgements

Supported by an educational grant from
GlaxoSmithKline

Related Content

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for gastroesophageal cancers

Manish A. Shah, MD Released: January 21, 2022

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for pancreatic and biliary tract cancers

Rachna Shroff, MD Released: January 21, 2022

Slides from Clinical Care Options (CCO) on biomarker testing to guide targeted therapy for colorectal cancer (CRC)

John L. Marshall, MD Released: January 21, 2022

In this commentary from Clinical Care Options (CCO), Asim V. Farooq, MD and Joann Kang, MD, provide guidance on monitoring and mitigating ocular toxicities associated with antibody-drug conjugates

Asim V. Farooq, MD Joann Kang, MD Released: January 20, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings